IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 174 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $198,000 | +88.6% | 20,707 | +277.0% | 0.01% | +75.0% |
| Q4 2021 | $105,000 | +303.8% | 5,492 | +422.5% | 0.00% | +300.0% |
| Q3 2021 | $26,000 | -97.6% | 1,051 | -97.4% | 0.00% | -97.1% |
| Q2 2021 | $1,069,000 | +871.8% | 41,070 | +927.8% | 0.04% | +191.7% |
| Q2 2020 | $110,000 | – | 3,996 | +14700.0% | 0.01% | – |
| Q3 2019 | $0 | -100.0% | 27 | -95.6% | 0.00% | -100.0% |
| Q2 2019 | $15,000 | -21.1% | 617 | -69.4% | 0.00% | -42.9% |
| Q1 2019 | $19,000 | -44.1% | 2,019 | +1.2% | 0.01% | -61.1% |
| Q1 2018 | $34,000 | – | 1,996 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |